公开(公告)号：US20080005921A1

公开(公告)日：2008-01-10

申请号：US11773725

申请日：2007-07-05

申请人： Thomas Gruber-Nadlinger ,  Gunter Halmschlager ,  Christoph Haase ,  Herbert Boden ,  Norbert Karner ,  Peter Kastner ,  Gunter Seitlhuber ,  Gerhard Holtmann ,  Andreas Figerl ,  Rainer Kloibhofer ,  Erich Rollenitz

发明人： Thomas Gruber-Nadlinger ,  Gunter Halmschlager ,  Christoph Haase ,  Herbert Boden ,  Norbert Karner ,  Peter Kastner ,  Gunter Seitlhuber ,  Gerhard Holtmann ,  Andreas Figerl ,  Rainer Kloibhofer ,  Erich Rollenitz

IPC分类号： F28F5/02 ,  F26B11/02 ,  D06F58/00

CPC分类号： D21F5/027 ,  D21F5/02 ,  D21F5/021

摘要： The invention relates to a device and a method for producing and/or transforming a web of fibrous material, in particular a paper or cardboard web. Said device includes a heatable and rotatable cylinder, in particular a drying cylinder of a drying section, and a cylinder sleeve which can be impinged from the inside by a heating fluid. In order to improve the heating power below the external surface of the cylinder sleeve, at least one channel is provided in order to guide the heating fluid.

摘要翻译： 本发明涉及用于生产和/或转化纤维材料纤维网，特别是纸或纸板网的装置和方法。 所述装置包括可加热和可旋转的气缸，特别是干燥部分的干燥筒，以及可通过加热流体从内部撞击的气缸套筒。 为了提高在气缸套的外表面下方的加热功率，提供至少一个通道以引导加热流体。

公开(公告)号：US20140065610A1

公开(公告)日：2014-03-06

申请号：US13590211

申请日：2012-08-21

申请人： Laurent Essioux ,  Carsten Horn ,  Johann Karl ,  Peter Kastner ,  Fabian Model ,  Giuseppe Palermo ,  Christina Rabe ,  Daniel Umbricht ,  Gabriel Vargas ,  Anne Vogt

发明人： Laurent Essioux ,  Carsten Horn ,  Johann Karl ,  Peter Kastner ,  Fabian Model ,  Giuseppe Palermo ,  Christina Rabe ,  Daniel Umbricht ,  Gabriel Vargas ,  Anne Vogt

IPC分类号： G01N33/68 ,  C12Q1/68

CPC分类号： G01N33/6896 ,  C12Q1/6883 ,  G01N21/76 ,  G01N33/543 ,  G01N33/54366

摘要： An in vitro method of predicting whether a patient, having a neurodevelopmental, neurological or neuropsychiatric disorder, will derive a clinical benefit if treated with a glycine reuptake inhibitor (GRI), via determination of the protein concentration of one, two, three, four five or six members of the complement factor H family or a mixture or a combination thereof and comparison against a representative value, wherein a higher value of the protein concentration in the patient's sample against the representative value is indicative of a patient whom will derive clinical benefit from treatment with GRI.

摘要翻译： 如果用甘氨酸再摄取抑制剂（GRI）进行治疗，预测具有神经发育，神经系统或神经精神障碍的患者是否将获得临床益处的体外方法，通过测定一，二，三，四五 或六个成员的补体因子H家族或其混合物或其组合，并与代表性值进行比较，其中患者样品中的蛋白质浓度的较高值代表代表性值，指示将从 用GRI治疗。